Medical Cannabis Technologies Inc. have signed a memorandum of understanding


Posted May 23, 2017 by KurtBurkhardt

Medical Cannabis Technologies Inc. and Privateer Holdings are pleased to announce that they have signed a memorandum of understanding (MOU)

 
Medical Cannabis Technologies Inc. and partners commit to the standardization of our treatments and patient wellness in Canada and Europe.
May 03, 2017 at 9:00am

Medical Cannabis Technologies Inc. and Privateer Holdings Sign MOU on Joint Venture.
VANCOUVER May. 03, 2017 /CNW/
Medical Cannabis Technologies Inc. (the “Company” or “MCT”) and Privateer Holdings are pleased to announce that they have signed a memorandum of understanding (“MOU”) to evaluate a partnership for the Canadian market with regard to the joint Venture centered on standardization of their treatments and patient wellness in Canada and Europe.
As part of the MOU, Privateer Holdings will, leading on from the non-binding letter agreement dated March 06, 2017, will subject to certain conditions precedent being satisfied; invest up to $8 million into Medical Technologies Inc.
Medical Technologies Inc. Has extensively researched the medical marijuana industry, and we find Medical Marijuana, Inc. to have far reaching Medical cures.
This collaborative effort to develop precise dosage, consistency and world class manufacturing is possible due to our research, industry experts, and regulatory compliance officers.
As we continue to develop new products for emerging markets, establishing an appropriate manufacturing relationship for these new markets was the natural next step in the process to teaming up with Privateer Holdings and their many investors.
Medical Cannabis Technologies Inc. has established itself as a world leader in cannabidiol (CBD) innovation and the group develops cannabis derived therapeutic grade CBD nutraceuticals and medical cannabis products with wide patient reach for human health.
Consequently, this agreement is a significant development for the company as it opens up an additional revenue stream and expands its presence in a familiar market where there is a need for the use for it to treat unmet medical conditions.
About Medical Cannabis Technologies Inc.
Medical Cannabis Technologies Inc. is an established organization devoted to the development and research of plant derived innovations in cannabinoid therapeutics, life sciences, intellectual property portfolios and drug discovery emphasizing on Medical Cannabis.

Strategically located in Canada where medical cannabis is legal at the Federal level and with our scientific expertise we own distinct intellectual property with regards to medical marijuana infused products.
Our company is one that is committed to providing the highest quality medical cannabis products with a deep pipeline of additional clinical stage ground breaking cannabinoid discoveries across a wide range of disease areas.
We are predominantly a biopharmaceutical company which is gearing up for our initial public offering on the TSX venture exchange whilst dual listing on the NASDAQ exchange, within the next quarter. As a company we are focused on discovering, developing and commercializing innovative and novel therapeutics from our proprietary cannabinoid product platform in a broad range of disease areas.

Cautionary Note on Froward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations. Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release. The Company assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

Email: [email protected]
Address: 1121 W Pender St, Vancouver, BC V6E Canada
https://www.medcannabtech.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Kurt Burkhardt
Country Canada
Categories Medical
Last Updated May 23, 2017